Pharmena S.A. (WSE:PHR)
3.590
-0.060 (-1.64%)
Sep 12, 2025, 1:26 PM CET
Pharmena Revenue
Pharmena had revenue of 386.00K PLN in the quarter ending June 30, 2025, with 160.81% growth. This brings the company's revenue in the last twelve months to 889.00K, up 205.50% year-over-year. In the year 2024, Pharmena had annual revenue of 268.00K, down -10.37%.
Revenue (ttm)
889.00K
Revenue Growth
+205.50%
P/S Ratio
45.10
Revenue / Employee
127.00K
Employees
7
Market Cap
40.10M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 268.00K | -31.00K | -10.37% |
Dec 31, 2023 | 299.00K | - | - |
Dec 31, 2022 | 299.00K | -14.91M | -98.03% |
Dec 31, 2021 | 15.21M | 5.28M | 53.16% |
Dec 31, 2020 | 9.93M | -1.17M | -10.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Diagnostyka | 2.17B |
NEUCA | 13.04B |
Synektik Spólka Akcyjna | 623.20M |
Voxel | 560.38M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |